X0306 4 2013-05-24 0001484478 Furiex Pharmaceuticals, Inc. FURX 0001202283 DIXON WENDY L C/O FURIEX PHARMACEUTICALS, INC., 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560 1 Common Stock 2013-05-24 5 A 0 3580 0 A 3580 D Stock Options (to buy) 9.11 2020-06-17 Common Stock 17570 17570 D Stock Options (to buy) 13.94 2021-05-19 Common Stock 8675 8675 D Stock Options (to buy) 13.45 2021-10-12 Common Stock 8825 8825 D Stock Options (to buy) 18.22 2022-05-24 Common Stock 17500 17500 D The restricted stock was awarded on 5/24/2013 and vests in its entirety on the earlier of 5/24/2014 or immediately prior to the 2014 Annual Stockholder meeting, provided that the Grantee is still at that time serving on the Company's Board of Directors. The options were awarded on 6/17/2010 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors. The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors. The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors. The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors. /s/ Donald R. Reynolds, by Power of Attorney 2013-05-29